CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Body By Design CHS

Body By Design Charleston is a locally owned and operated med spa that offers body sculpting treatments using UltraShape and VelaShape III. They also offer facial rejuvenation treatments and sell skincare products.

Besafemeds

Besafemeds takes today`s technology and applies it to healthcare to deliver a discreet treatment option for STDs. We store no identifiable data on our users. Once a determination is made that a prescription is needed and subsequently transmitted to the pharmacy of your choice, all identifiable data is purged from the system. Besafemeds is staffed by physicians and nurse practitioners following standard treatment guidelines for the two most common STDs (gonorrhea and chlamydia). In an ideal world, testing should occur before treatment. However, besafemeds is here for those who need or want a discreet and quick STD treatment option.

Fox Hill Village

Fox Hill Village is a retirement community located in Westwood, Massachusetts that offers independent senior living, assisted living, rehabilitation, and memory care options. The community features 340 resident-owned apartments surrounding a village co...

INFOHEALTH Management

INFOHEALTH Management Corp. is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Crouse

Crouse Hospital has been caring for generations of Central New Yorkers since 1887. Our mission is to provide the best in patient care by exceeding the expectations of our patients and to promote community health. A private, not-for-profit hospital, Crouse is licensed for 506 acute-care beds and 57 bassinets. We serve more than 23,000 inpatients, 66,000 emergency services patients and more than 250,000 outpatients a year from a 15-county area in Central and Northern New York.